SUMMARY Methionine given parenterally to rats caused rapid disappearance of methyltetrahydrofolate from the liver and a corresponding rise in tetrahydrofolate and formyl-tetrahydrofolate concentrations. When ['4C]H3-H4folate was given, methionine caused an increased [1'4C]02 excretion, indicating that oxidation of the methyl group had occurred. Methionine was more effective than Sadenosylmethionine at causing oxidation, but serine was ineffective.
which natural folates are absorbed from the gut into portal blood. It is also the dominant analogue in plasma and the only form offolate in the cerebrospinal fluid. The manner in which methylfolate is formed and metabolised is central to understanding the interaction between cobalamin and folate, and these aspects have been reviewed. ' 5-Methyl-tetrahydrofolate is formed by reduction of 5,10-methylenetetrahydrofolate. The enzyme is 5, 10-methylenetetrahydrofolate reductase, and in vitro the reaction is noticeably shifted in the direction of methylfolate synthesis. On the basis of in vitro studies the reverse reaction, involving oxidation of methylfolate, is regarded as unlikely.
The methyl group of 5-CH3-H4PteGlu is transferred to homocysteine by methionine synthetase in the de novo synthesis of methionine. This is said to be the only means for the disposal of the methyl group of methylfolate. Failure of the methionine synthetase reaction, which occurs in cobalamin deficiency or in cobalamin inactivation by nitrous oxide, may lead to accumulation of 5-CH3-H4PteGlu and subsequent "trapping" offolate. This has been termed the methylfolate trap hypothesis.23
Accepted for publication 19 May 1988 When these ideas were put forward,3 it was also noted that methionine had considerable effects on the distribution of folate analogues in rat livers. The authors found that 1% methionine added to the rat diet and fed for 24 hours before sacrifice considerably increased the amount of tetrahydrofolate and formyltetrahydrofolate at the expense of methyltetrahydrofolate. This occurred in both control and experimental animals. The mechanism of this redistribution was not established, although it was conjectured that methionine might provide a methyl group acceptor via S-adenosylhomocysteine derived from demethylation of S-adenosylmethionine.
The effect of methionine in lowering CH3-H4Pte-Glu and increasing H4PteGlu and CHO-H4PteGlu concentrations in liver has been confirmed most recently by Brody et al, who showed that 300 Mmol of methionine in the rat virtually removed all hepatic methylfolate within 30 minutes. They too did not comment on how this occurred. They used cobalamininactivated rats so that the methyl group could not have been passed on to homocysteine. 4 S-adenosylmethionine in vitro inhibits the activity of the enzyme methylene tetrahydrofolate reductase and so inhibits further synthesis of methylfolate. On this basis the concentration of S-adenosylmethionine has been assumed to be the main regulatory factor in the rate of methylfolate synthesis.
The validity of these views are of importance in understanding folate and one-carbon unit metabolism and how cobalamin deficiency produces its effects. The purpose of this study was to explore how methionine and related compounds changed the concentrations of 1158
In vivo oxidation of the methyl group ofhepatic 5-methyltetrahydrofolate methylfolate in rat livers, and in particular to obtain evidence for the in vivo oxidation of the methyl group of methylfolate to formate and carbon dioxide. After centrifugation at 3000 x g for 30 minutes the supernatant was applied to a column of DEAE cellulose (Whatman DE52). Folate monoglutamates were separated using a non-linear salt gradient. The mixing chamber contained 150 ml of 0-IM potassium phosphate (pH 6-0), to which was added 0-2M 2-mercaptoethanol. The reservoir contained 350 ml of 1 0M potassium phosphate (pH 6-0) with 0O2M 2-mercaptoethanol. Fractions (5 ml) were collected, all the folates eluting before fraction 50. Folates were identified by elution postion and measured by microbiological assay with Lactobactillus casei (NCIMB 8081). 5-CHO-H4PteGlu was measured using Pediococcus cerevisiae (NCIMB 7837)). As 5-formyl-and 5-methyl-H4PteGlu elute very close together and 5-methyl-H4PteGlu is inactive for P cerevisiae, P cerevisiae assay was used as a measure of 5-formylfolate.
Material and methods

Methionine
Amounts of each folate were expressed as the percentage of the total folate.
[14CJ02 PRODUCTION 5-([C4H3-H4PteGlu specific activity 60 mCi/mmol, was obtained from Amersham Internation. Ten Sprague Dawley rats were exposed to N20/02 (1/1) in a specially constructed perspex chamber. After four days half the rats were given an intraperitoneal injection containing 300 umol ofmethionine and 2 pCi 5-[1C4H3-H4PteGlu alone. The animals were then placed in individual chambers through which nitrous oxide and oxygen continued to be passed. Expired carbon dioxide was collected by passing the outflow from the chambers through two vessels connected in series, each containing 50 ml of2M potassium hydroxide. The efficiency of this system was checked by passing the outflow of the second vessel through a solution of barium hydroxide (50 g/l). No precipitate was formed. One ml samples ofthe potassium hydroxide were taken every hour into 10 ml NE260 (Nuclear Enterprises) and counted on a LKB Betarak liquid scintillation counter. Quench corrections were made by the channels ratio method using an external standard. tioin was accompanied by a parallel increase in CHO-H4PteGlu and H4PteGlu (table 1 and fig 3) , implying oxidation ofthe methyl groups to formyl and carbon dioxide (fig 1) . In vivo oxidation of the methyl group ofhepatic 5-methyltetrahydrofolate trations (table 3 and fig 4) . Due to toxicity of 5'-methylthioadenosine, doses greater than 16 umol were not tested.
EFFECT OF OTHER COMPOUNDS ON FOLATE ANALOGUES IN LIVER
Neither serine nor formate (table 4 and fig 4) had any effect on methylfolate concentrations in liver but both glycine and betaine had an effect that was comparable with an equimolar dose of S-adenosylmethionine.
Discussion
Kutzbach and Stokstad suggested that the concentration of methylfolate in liver is regulated by control of the rate of its synthesis.5 S-adenosylmethionine inhibited the acitivity of methylenetetrahydrofolate reductase which reduces methylene-H4PteGlu to methyl-H4PteGlu. Our data suggest that the concentration ofmethylfolate in liver is more finely attuned to that of methionine. Excess methionine is toxic and its increase leads to rapid conversion ofthe methyl group ofmethylfolate to more oxidised forms, and presumably to the end of methionine synthesis. This oxidation occurs in both B12-deficient2 and B12-inactivated animals (unpublished observations) as well as in healthy animals. The amount of methionine producing this effect can be as little as 0-5 ymol, which is well below the normal daily intake in a rat. S-adenosylmethionine was less effective than methionine and suggests that S-adenosylmethionine concentrations are less important than methionine in regulating methylfolate metabolism. Indeed, the activity of Sadenosylmethionine was related to the amount of methionine regenerated. The data have implications for the methylfolate trap hypothesis, which assumes that the methyl group of methylfolate is not oxidised. Even in the absence of a methionine supplement the B,2-inactivated animal is able to dispose of the methyl group ofmethylfolate by Lumb, Chanarin, Deacon, Perry oxidation.6 This is enhanced considerably by raising the methionine intake.
Accumulation of methylfolate occurs in B,2-inactivation, primarily because of the failure of the methionine synthetase reaction. The hepatic concentration ofmethylfolate reaches its peak within hours of exposure to nitrous oxide but thereafter falls and remains at a plateau after seven days. This methylfolate is metabolically active in so far as it serves as a substrate for the synthesis ofpolyglutamate with up to five glutamic acid residues. The absence ofmethylhexaglutamate has suggested oxidation of the methyl group from the hexaglutamate in accordance with the observations of Brody, Watson, and Stokstad.4 Addition of a methionine supplement is accompanied by oxidation of methylfolate within minutes, so that it seems unlikely that this occurs from methylhexaglutamate alone but probably from methylfolates of variable chain length, including monoglutamates.
The confirmation of the in vivo oxidation of the methyl group of methylfolate in both healthy and B,2-inactivated animals removes one of the central pivots of the methylfolate trap hypothesis. There are other equally important observations, however, that are not accounted for by methylfolate trapping.' Firstly, the most important is the failure of B,2-deficient or B,2-inactivated cells to use H4PteGlu in a normal manner. Thus H,PteGlu failed to correct the defect in the dU suppression test in marrow cells from patients with untreated pernicious anaemia. This was confirmed with rat marrow from animals exposed to nitrous oxide. Further H4PteGlu was not used as substrate for folate polyglutamate synthesis in liver in rats exposed overnight to nitrous oxide.
Secondly, the impairment of both thymidine synthesis in the dU suppression test and of folate polyglutamate synthesis in the B,2-inactivated rat was reversed completely if folate carrying a carbon unit at the formate level of oxidation was provided. The most convenient was 5-formyl-tetrahydrofolate, but 10-formyl-tetrahydrofolate and 5,10-methenyl-tetrahydrofolate were equally effective.
Thirdly, the defects due to B,2-inactivation were reversed by supplying a compound that yielded formate. The most interesting was 5'-methylthioadenosine, which is derived from S-adenosylmethionine and is reconverted to methionine, yielding a mole of formate for each mole methionine regenerated. This compound was much more effective than methionine itself in reversing the effects of B,2 deficiency.
